Lev M Kats

15PUBLICATIONS
92CO-AUTHORS
Characterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 04, 2025
Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity.

Olivia Susanto, Emily Gruber, Cheng Mun Wun

|Jul 03, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.

Kevin Sek, Amanda X Y Chen, Thomas Cole

|Apr 02, 2025
Epigenetic reprogramming in multiple myeloma-Challenges and opportunities.

Subhasree Kumar, Lev M Kats, Emily Gruber

|Apr 10, 2024
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.

Jack D Chan, Christina M Scheffler, Isabelle Munoz

|Aug 29, 2023
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma.

Danielle H Oh, Xiao Ma, Simon J Hogg

|Aug 01, 2023
The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches.

Emily Gruber, Lev M Kats

Pageof 3

Frequent Collaborators

5 joint publications

Ricky W Johnstone

4 joint publications

Emily Gruber

3 joint publications

Paul A Beavis

3 joint publications

Ian A Parish